← Leaderboards
Peter James Turnbaugh
University Of California, San Francisco
$13,182,280
Attributed
$15,057,636
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,057,636 · 6
By mechanism
R01$14,679,628 · 5
R21$378,008 · 1
Top collaborators
- Jose U. Scher5 shared
- Chloe E. Atreya2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- June Ml Chan$5,249,942
- James A Wells$24,064,501
- Chloe E. Atreya$2,763,065
- Senen Dario Mendoza$40,475
Others in their field
Top investigators on “Microbiome”
- James E. Gern · University Of Wisconsin-Madison$135,210,239
- Jeffrey P Krischer · University Of South Florida$110,106,410
- Richard A Gibbs · Baylor College Of Medicine$97,085,750
- Mine Cicek · Mayo Clinic Rochester$80,808,856
- Richard K. Wilson · Washington University$72,151,126
- Stephen Norman Thibodeau · Mayo Clinic Rochester$70,215,522
Research focus
MicrobiomeGut MicrobiomeGut BacteriaGenesMetabolismPharmaceutical PreparationsCellsMicrobialInsightPharmacologyDrug MetabolismGnotobioticIntestinesGrowthBiological AvailabilityIn VitroGeneticGut MicrobiotaActinobacteria ClassBaseOralHuman MicrobiomePositioning AttributePrograms
Grant awards (35)
Metabolism of cancer chemotherapeutics by the human gut microbiome$601,043
R01 · FY2025 · CA · contact PI
Metabolism of cancer chemotherapeutics by the human gut microbiome$131,453
R01 · FY2025 · CA · contact PI
Metabolism of cancer chemotherapeutics by the human gut microbiome$130,511
R01 · FY2025 · CA · contact PI
Predicting and preventing drug metabolism by the human gut microbiome$631,994
R01 · FY2024 · HL · contact PI
Metabolism of cancer chemotherapeutics by the human gut microbiome$573,622
R01 · FY2024 · CA · contact PI
Host-microbiome interactions shape the metabolic effects of ketogenic diets$490,405
R01 · FY2024 · DK · contact PI
Metabolism of cancer chemotherapeutics by the human gut microbiome$130,605
R01 · FY2024 · CA · contact PI
Metabolism of cancer chemotherapeutics by the human gut microbiome$129,622
R01 · FY2024 · CA · contact PI
Employing the gut microbiome to accelerate effective initiation of rheumatoid arthritis therapy$655,381
R01 · FY2023 · AR
Predicting and preventing drug metabolism by the human gut microbiome$646,398
R01 · FY2023 · HL · contact PI
Metabolism of cancer chemotherapeutics by the human gut microbiome$603,222
R01 · FY2023 · CA · contact PI
Host-microbiome interactions shape the metabolic effects of ketogenic diets$529,623
R01 · FY2023 · DK · contact PI
Establishing the feasibility of editing the human gut microbiome$403,750
R01 · FY2023 · AT · contact PI
Employing the gut microbiome to accelerate effective initiation of rheumatoid arthritis therapy$657,333
R01 · FY2022 · AR
Predicting and preventing drug metabolism by the human gut microbiome$649,975
R01 · FY2022 · HL · contact PI
Host-microbiome interactions shape the metabolic effects of ketogenic diets$567,474
R01 · FY2022 · DK · contact PI
Establishing the feasibility of editing the human gut microbiome$403,750
R01 · FY2022 · AT · contact PI
Predicting and preventing drug metabolism by the human gut microbiome$76,620
R01 · FY2022 · HL · contact PI
Predicting and preventing drug metabolism by the human gut microbiome$62,110
R01 · FY2022 · HL · contact PI
Predicting and preventing drug metabolism by the human gut microbiome$651,853
R01 · FY2021 · HL · contact PI
Employing the gut microbiome to accelerate effective initiation of rheumatoid arthritis therapy$647,865
R01 · FY2021 · AR
Host-microbiome interactions shape the metabolic effects of ketogenic diets$559,712
R01 · FY2021 · DK · contact PI
Establishing the feasibility of editing the human gut microbiome$403,750
R01 · FY2021 · AT · contact PI
Employing the gut microbiome to accelerate effective initiation of rheumatoid arthritis therapy$677,759
R01 · FY2020 · AR
Predicting and preventing drug metabolism by the human gut microbiome$480,713
R01 · FY2020 · HL · contact PI
Establishing the feasibility of editing the human gut microbiome$403,750
R01 · FY2020 · AT · contact PI
Host-microbiome interactions shape the metabolic effects of ketogenic diets$395,203
R01 · FY2020 · DK · contact PI
Employing the gut microbiome to accelerate effective initiation of rheumatoid arthritis therapy$734,366
R01 · FY2019 · AR
Predicting and preventing drug metabolism by the human gut microbiome$393,235
R01 · FY2019 · HL · contact PI
(PQ10) Harnessing the human gut microbiome to predict chemotherapy outcomes$169,262
R21 · FY2019 · CA · contact PI
Predicting and preventing drug metabolism by the human gut microbiome$79,387
R01 · FY2019 · HL · contact PI
Predicting and preventing drug metabolism by the human gut microbiome$392,803
R01 · FY2018 · HL · contact PI
(PQ10) Harnessing the human gut microbiome to predict chemotherapy outcomes$208,746
R21 · FY2018 · CA · contact PI
Predicting and preventing drug metabolism by the human gut microbiome$392,378
R01 · FY2017 · HL · contact PI
Predicting and preventing drug metabolism by the human gut microbiome$391,963
R01 · FY2016 · HL · contact PI